Skip to main content
Figure 1 | BMC Cancer

Figure 1

From: A retrospective chart review of drug treatment patterns and clinical outcomes among patients with metastatic or recurrent soft tissue sarcoma refractory to one or more prior chemotherapy treatments

Figure 1

Systemic therapy treatment patterns. Treatment patterns according to (A) therapy line, and (B) second-line and third-line systemic therapy received according to histological subtype. *Patients were required to have at least one second-line systemic therapy for soft tissue sarcomas to be eligible for this study. Therefore, the first-line therapy distribution was based on those patients receiving at least one additional line of therapy (i.e. second-line or second-line plus additional lines of therapy).

Back to article page